Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Clinical trial NCT02833948 · COMPLETED

Trial details

NCT number: NCT02833948
Sponsor: ECRI bv
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Aortic Valve Stenosis Cardiovascular Diseases Heart Valve Diseases Ventricular Outflow Obstruction Thrombosis

Start date: 2016-05-01
Primary completion: 2018-12-01
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.